Related Experiment Video
Updated: Apr 21, 2026
07:44
In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
3.6K
Proceedings: debilitating eye diseases.
Ingrid W Caras1, Neil Littman2, Arie Abo2
1California Institute for Regenerative Medicine, San Francisco, California, USA icaras@cirm.ca.gov.
Stem Cells Translational Medicine
|November 8, 2014
Summary
Stem cell therapy offers a promising new avenue for treating debilitating eye diseases like age-related macular degeneration and retinitis pigmentosa. Research is advancing novel stem cell treatments to address these significant unmet medical needs.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cellular Therapy
Background:
- Age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are leading causes of irreversible blindness.
- Current treatments for AMD and RP are limited, creating a substantial unmet medical need.
- Stem cell therapy presents a potential therapeutic strategy for restoring vision in patients with these conditions.
Purpose of the Study:
- To discuss novel stem cell-based therapies for eye diseases.
- To highlight the approaches being developed by the California Institute for Regenerative Medicine (CIRM) and its grantees.
- To provide an overview of the current landscape of stem cell research in ophthalmology.
Main Methods:
- Review of ongoing stem cell therapy research and development in ophthalmology.
- Focus on initiatives and projects funded by the California Institute for Regenerative Medicine.
- Discussion of various stem cell types and delivery methods being investigated.
Main Results:
- Several novel stem cell-based therapeutic approaches are under active development for various eye conditions.
- CIRM is actively supporting research in this field through its grant programs.
- Progress is being made in translating stem cell research from the laboratory to clinical applications.
Conclusions:
- Stem cell therapy holds significant promise for addressing unmet needs in treating blinding eye diseases.
- Continued research and investment, particularly through organizations like CIRM, are crucial for advancing these therapies.
- The development of stem cell-based treatments could revolutionize the management of conditions like AMD and RP.
Related Concept Videos
01:22Photoreceptors and Visual Pathways
11.3K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.3K
01:17Accessory Structures of the Eye
4.8K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
4.8K
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:27Diabetic Retinopathy
11
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11